WO2004037019A1 - Compositions de metal capables de supprimer l'oxygene actif - Google Patents
Compositions de metal capables de supprimer l'oxygene actif Download PDFInfo
- Publication number
- WO2004037019A1 WO2004037019A1 PCT/JP2002/011145 JP0211145W WO2004037019A1 WO 2004037019 A1 WO2004037019 A1 WO 2004037019A1 JP 0211145 W JP0211145 W JP 0211145W WO 2004037019 A1 WO2004037019 A1 WO 2004037019A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- active oxygen
- gold
- platinum
- oxygen radical
- foil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3409—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor
- A23L3/3418—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor in a controlled atmosphere, e.g. partial vacuum, comprising only CO2, N2, O2 or H2O
- A23L3/3427—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor in a controlled atmosphere, e.g. partial vacuum, comprising only CO2, N2, O2 or H2O in which an absorbent is placed or used
- A23L3/3436—Oxygen absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Definitions
- the present invention relates to a metal composition having an ability to scavenge reactive oxygen radicals (Reactive Oxygen Radica1).
- Background art Reactive Oxygen Radica1.
- Active oxygen radicals also called simply active oxygen or free radicals, are reactive atoms and molecules with unstable unpaired electrons.
- reactive oxygen radicals In general, super O key side (- 0 2 -), hydroxy radicals (HO *), hydrogen peroxide (H 2 0 2), 4 kinds of singlet oxygen 0 2) is referred to as reactive oxygen radicals.
- hydroperoxy radicals (HOO *), peroxy radicals (L 00 *), alkoxy radicals (LO *) and the like are also broadly called active oxygen species and radical species.
- active oxygen radicals are produced secondary and tertiary from active oxygen radicals.
- active oxygen radicals which increase at an accelerated rate, cause damage to cells and DNA, peroxidation of lipids, and are involved in many diseases.
- active oxygen radical scavengers have two aspects: elimination of active oxygen and generation of active oxygen.
- the active oxygen radical scavenger which is a hydrogen (H *) donor, is converted into an active oxygen radical such as 0 *, HOOH, HO 0 *, and HO * (HOOH in the above equation). It donates two electrons (e-one) and reduces by two protons (H +) to eliminate active oxygen radicals.
- the normal oxygen molecule O 2 two electrons (e-), donate two protons (H +), thereby generating an active oxygen Also involved in the process.
- active oxygen radical scavengers and media such as aldehydes, amino acids, and peronic acid (acidic saccharides), which have poor direct working ability to process active oxygen radicals alone, are present at the same time. It was revealed that the active oxygen radical scavenger was superior to the active oxygen radical scavenger in eliminating the active oxygen than the active oxygen radical scavenger alone. In addition, it was revealed that there was a combination of active oxygen radical scavenger and mediae in the reaction to eliminate active oxygen radicals.
- active oxygen radical X hereinafter sometimes simply referred to as “X” in the present specification
- active oxygen radical scavenger Y hereinafter referred to as the “donor”
- Y active oxygen radical scavenger
- k Constant reflecting the active oxygen radical processing ability mainly by the combination of Y and Z
- test substance if a faint luminescence phenomenon can be observed in the test substance under the coexistence of X and Y, it can be recognized that the test substance is a medium-Z. In addition, if a weak emission phenomenon can be observed in the test substance under the coexistence of X and Z, the test substance can be recognized as the active oxygen radical scavenger Y.
- test substance is a substance consisting of the active oxygen radical X and the media Zi.
- test substance is a substance consisting of the active oxygen radical X and the active oxygen radical force ranger Y. Can be.
- the phenomenon of the weak light emission (hereinafter, sometimes referred to as “XYZ-based weak light emission” in the present specification) is a basic phenomenon in an oxygen environment, and is a basic and universal phenomenon that occurs near us. This phenomenon is based on the elimination of the active oxygen radical X by converting it into light energy.
- ⁇ works as a hydrogen ( ⁇ *) donor and ⁇ works as a mediator.
- ⁇ can be said to be a second scavenger because even if the activity of ⁇ , called a scavenger, is high, light energy cannot be released without the presence of ⁇ .
- the world of media in the ⁇ -based active oxygen-eliminated luminescence is a completely unknown world with no concept.
- the skin, digestive organs, respiratory organs, heart, blood vessels, eyes, brain, bones, and genitalia of the body are all ⁇ , and play an important role as a mediator of hydrogen in active oxygen scavenging luminescence. Disclosure of the invention
- the inventor of the present application has analyzed the components of various substances having the ability as a media, and as a result of diligent research, found that gold, platinum, silver, and copper have the ability as a media. After elucidation, the present invention was completed.
- the metal composition having the active oxygen scavenging ability proposed by the present invention is made of one or more of gold, platinum, silver, and copper.
- the metal composition of the present invention is 24 gold, 23.9 gold, 23.74 gold, 23.44 gold, 23.21 gold, 22.99 gold, 22.66 gold, 21.68 gold, 18.12 gold , 14.12 gold.
- Table 1 shows the gold, silver and copper content ratios. Table 1 Content of gold, silver and copper
- the shape of gold, platinum, silver, and copper is not particularly limited, but is preferably foil, flake, powder, or granule because the larger the surface area, the higher the capacity of the media becomes. However, if the particle size is reduced, the surface area increases, but in consideration of the cost, foil or flake is more preferable.
- the thickness should be about 0.1 to 0.3 zm, which is the intermediate product of foil or about 0.1 to 0.3 zm obtained by further hammering the supernatant. I like it.
- the content ratio by weight of gold to platinum is preferably 0.01 to 100 with respect to platinum 1.
- the weight ratio of gold to platinum if the amount of gold is less than 0.01 with respect to platinum 1, it is not preferable because the effect of gold is hardly observed, and conversely, it exceeds 100. Because the effect of platinum is not produced, it is unfavorable.
- the active oxygen-eliminated luminescence as Z by XY was observed, but the active oxygen-eliminated luminescence as Y by XZ, the active oxygen-eliminated luminescence as XZ by Y, and the XY as XY by Z. No active oxygen-quenched luminescence was observed. Therefore, the gold leaf is recognized as the medial oxygen Z, but it is not the active oxygen radical scavenger Y, but the active oxygen radical X and the media oxygen Z, but not the active oxygen radical X. It was found that it was not a substance consisting of the active oxygen radical scavenger Y.
- Example 2 Flaky 24 gold foil, flaky 23.9 gold foil, flaky 18.12 gold foil, flaky 14.12 gold foil, flaky 100% platinum foil, flaky 100% silver foil, flaky 100% The active oxygen-eliminated luminescence as Z by XY was measured for each of the copper foil and the flaky aluminum foil.
- Petri dish 5 is flaked 24 gold leaf
- Petri dish 6 is flaked 23.9 gold leaf
- Petri dish 7 is flaked 18.12 gold foil
- Petri dish 8 is flaked 14.12 gold foil
- Petri dish 9 is flaked 100% platinum foil
- Petri dish 10 is flaked 1 ⁇ 0% silver foil
- the Petri dish 11 was a flaky 100% copper foil
- the Petri dish 12 was a flaky aluminum foil.
- the faint emission of the dish 5-12 is detected by the CCD camera performs Fuotonkau down computing, further from the light emission luminance displayed by performing the image processing, the brightness of the active oxygen scavenging emission as Z by XY (cd / m 2 ).
- the metal composition of the present invention has a capability as a media, and has excellent active oxygen scavenging ability, and is therefore useful for maintaining and recovering human health and physical condition. Therefore, the metal composition of the present invention is highly versatile and is expected to be widely used as a raw material for cosmetics, pharmaceuticals, health foods and general foods.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002343768A AU2002343768A1 (en) | 2002-10-28 | 2002-10-28 | Metal compositions capable of removing active oxygen |
PCT/JP2002/011145 WO2004037019A1 (fr) | 2002-10-28 | 2002-10-28 | Compositions de metal capables de supprimer l'oxygene actif |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2002/011145 WO2004037019A1 (fr) | 2002-10-28 | 2002-10-28 | Compositions de metal capables de supprimer l'oxygene actif |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004037019A1 true WO2004037019A1 (fr) | 2004-05-06 |
Family
ID=32170793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/011145 WO2004037019A1 (fr) | 2002-10-28 | 2002-10-28 | Compositions de metal capables de supprimer l'oxygene actif |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002343768A1 (fr) |
WO (1) | WO2004037019A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1598071A4 (fr) * | 2003-02-20 | 2006-04-26 | Shetech Co Ltd | Agent de decomposition d'un anion superoxyde |
EP1656840A1 (fr) * | 2004-11-08 | 2006-05-17 | Fuji Photo Film Co., Ltd. | Agent pour l'élimination de l'oxygène et méthode de production |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011117A2 (fr) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Complements alimentaires comprenant des vitamines et des sels mineraux |
JPH1160493A (ja) * | 1997-08-18 | 1999-03-02 | Eiichi Tsukiji | 活性酸素を起因とする疾患の治療および予防薬又はその原料 |
JPH11346715A (ja) * | 1998-06-09 | 1999-12-21 | Otsuka Yakuhin Kogyo Kk | 白金族コロイド溶液を配合した食品の製造方法 |
WO2001036337A1 (fr) * | 1999-11-18 | 2001-05-25 | Phild Co., Ltd. | Procede et dispositif de preparation d'une eau contenant des particules d'or ultrafines dissoutes |
-
2002
- 2002-10-28 AU AU2002343768A patent/AU2002343768A1/en not_active Abandoned
- 2002-10-28 WO PCT/JP2002/011145 patent/WO2004037019A1/fr not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011117A2 (fr) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Complements alimentaires comprenant des vitamines et des sels mineraux |
JPH1160493A (ja) * | 1997-08-18 | 1999-03-02 | Eiichi Tsukiji | 活性酸素を起因とする疾患の治療および予防薬又はその原料 |
JPH11346715A (ja) * | 1998-06-09 | 1999-12-21 | Otsuka Yakuhin Kogyo Kk | 白金族コロイド溶液を配合した食品の製造方法 |
WO2001036337A1 (fr) * | 1999-11-18 | 2001-05-25 | Phild Co., Ltd. | Procede et dispositif de preparation d'une eau contenant des particules d'or ultrafines dissoutes |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1598071A4 (fr) * | 2003-02-20 | 2006-04-26 | Shetech Co Ltd | Agent de decomposition d'un anion superoxyde |
US7838043B2 (en) | 2003-02-20 | 2010-11-23 | Apt Co., Ltd | Superoxide anion decomposing agent |
EP1656840A1 (fr) * | 2004-11-08 | 2006-05-17 | Fuji Photo Film Co., Ltd. | Agent pour l'élimination de l'oxygène et méthode de production |
Also Published As
Publication number | Publication date |
---|---|
AU2002343768A8 (en) | 2004-05-13 |
AU2002343768A1 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Karakoti et al. | Redox-active radical scavenging nanomaterials | |
Jourd'Heuil et al. | Effect of Superoxide Dismutase on the Stability ofS-Nitrosothiols | |
Sokolova et al. | In vitro antioxidant properties of red algal polysaccharides | |
Yu et al. | The inhibitory effect of selenium nanoparticles on protein glycation in vitro | |
Bonaventura et al. | A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation | |
JP5636146B2 (ja) | アスコルビン酸のグリセリン懸濁液 | |
Verma et al. | Nanocomposite of Ag nanoparticles and catalytic fluorescent carbon dots for synergistic bactericidal activity through enhanced reactive oxygen species generation | |
Grootveld et al. | Potential advantages of peroxoborates and their ester adducts over hydrogen peroxide as therapeutic agents in oral healthcare products: chemical/biochemical reactivity considerations in vitro, ex vivo and in vivo | |
WO2010061921A1 (fr) | Procédé de stabilisation de l'acide l-ascorbique, préparation par extraction de liquide, extrait solide, et extrait semi-fluide | |
Sallak et al. | Antimicrobial biodegradable film based on corn starch/Satureja khuzestanica essential oil/Ag–TiO2 nanocomposites | |
Mohapatra et al. | Biosynthesized Ag–ZnO nanohybrids exhibit strong antibacterial activity by inducing oxidative stress | |
CN113272255B (zh) | 以羧酸有机化的硅离子复合物及复合物的制备方法和利用其的产品 | |
WO2004037019A1 (fr) | Compositions de metal capables de supprimer l'oxygene actif | |
KR20140086957A (ko) | 은 이온 항균액의 생성방법, 그 방법으로 생성되는 은 이온 항균액, 또는 은 이온 항균 분말의 생성방법, 그 방법으로 생성되는 은 이온 항균 분말 | |
CN111820239A (zh) | 一种液体组合物及其制备方法与应用 | |
Kolodziejczyk et al. | In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components | |
US20110300239A1 (en) | Blood flow improving agent | |
JP4922779B2 (ja) | 歯牙用漂白剤組成物 | |
Kumar et al. | The biocompatible validity of amino acid ionic liquid mediated gold nanoparticles for enhanced activity and structural stability of papain | |
US9018252B2 (en) | Stable compositions of dehydroascorbic acid | |
JP6895436B2 (ja) | 2−O−α−D−グリコシル−L−アスコルビン酸金属塩、その酸化防止剤としての用途及びその粉末の製造方法 | |
JP2002293725A (ja) | 歯用ホワイトニング剤及びそれを用いた歯の漂白方法 | |
JP2004131611A (ja) | 石鹸 | |
JP2001302530A (ja) | 還元型抗酸化物質及びその製造方法 | |
Xu et al. | A mussel glue-inspired monomer-etchant cocktail for improving dentine bonding |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |